2N Pharma ApS: Financial statements 2022
CVR: 41169303
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
2N Pharma ApS (CVR 41169303) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,221,899 and a net result of DKK 270,099 compared with DKK -318,464 the year before. That is an increase of 44.5% compared with the year before. Equity in the 2022 report amounted to DKK 11,048,047. The solvency ratio was 56.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,221,899
- Profit/Loss
- DKK 270,099
- Equity
- DKK 11,048,047
- Total Assets
- DKK 19,662,594
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.2 mio. | 270 t. | 11 mio. | 3 |
| 2021 | - | 1.5 mio. | -318 t. | 8.9 mio. | 5 |
| 2020 | - | 336 t. | -188 t. | -148 t. | 1 |
Official annual report
Keep an eye on 2N Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
2N Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,538,094, and the net result was DKK -318,464.
About 2N Pharma ApS
2N Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2020. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by 2N Pharma Holding ApS. According to the 2024 annual report, the company had an average of 3 employees. In 2024, the company reported a gross profit of DKK 1,077,483 and a net result of DKK -396,379 compared with DKK -346,799 the year before. Equity in the 2024 report amounted to DKK 10,304,869.